Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders
Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2431927, titled, “5-Lipoxygenase Activating Protein (FLAP) Inhibitors,” which includes coverage of Amira’s AM103 and AM803 FLAP inhibitors for the treatment of respiratory disorders.

Read more on News-Medical-Net

Leave a Reply

Your email address will not be published. Required fields are marked *